PartnershipJun 24, 2026, 07:06 AM
OrthoPediatrics Partners with OSSIO for Metal-Free Fixation Tech
AI Summary
OrthoPediatrics Corp. announced an exclusive distribution agreement with OSSIO, Inc. to bring bio-integrative, metal-free fixation technology to U.S. children's hospitals. This OSSIOfiber® technology is designed to be replaced by the patient's newly formed bone, thereby decreasing the need for secondary hardware removal surgeries common with metal implants. The partnership expands OrthoPediatrics' product offering, addresses unmet pediatric needs, and is expected to strengthen the company's long-term growth potential.
Key Highlights
- OrthoPediatrics announced an exclusive distribution agreement with OSSIO, Inc.
- Agreement brings OSSIOfiber® bio-integrative, metal-free fixation technology to U.S. children's hospitals.
- OSSIOfiber implants are gradually replaced by new bone, reducing need for secondary surgeries.
- Implants integrate into bone tissue within 18-24 months post-implantation.
- Partnership expands OrthoPediatrics' product offering and addresses unmet pediatric needs.
- Expected to strengthen OrthoPediatrics' long-term growth potential.
Price Impact
More from KIDS